• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Am J Public Health . Slow Spread of SARS-CoV-2 in Southern Brazil Over a 6-Month Period: Report on 8 Sequential Statewide Serological Surveys Includ

tetano

Editor, Senior Moderator
Am J Public Health


. 2021 Jun 29;e1-e9.
doi: 10.2105/AJPH.2021.306351. Online ahead of print.
Slow Spread of SARS-CoV-2 in Southern Brazil Over a 6-Month Period: Report on 8 Sequential Statewide Serological Surveys Including 35611 Participants


Pedro C Hallal[SUP] 1 [/SUP], Mariangela F Silveira[SUP] 1 [/SUP], Ana M B Menezes[SUP] 1 [/SUP], Bernardo L Horta[SUP] 1 [/SUP], Aluísio J D Barros[SUP] 1 [/SUP], Lucia C Pellanda[SUP] 1 [/SUP], Gabriel D Victora[SUP] 1 [/SUP], Odir A Dellagostin[SUP] 1 [/SUP], Claudio J Struchiner[SUP] 1 [/SUP], Marcelo N Burattini[SUP] 1 [/SUP], Marilia A Mesenburg[SUP] 1 [/SUP], Nadege Jacques[SUP] 1 [/SUP], Luís Paulo Vidaletti[SUP] 1 [/SUP], Emanuele L Ambros[SUP] 1 [/SUP], Evelise M Berlezi[SUP] 1 [/SUP], Helena Schirmer[SUP] 1 [/SUP], Jane D P Renner[SUP] 1 [/SUP], Kaue Collares[SUP] 1 [/SUP], Maria Letícia R Ikeda[SUP] 1 [/SUP], Thiago M Ardenghi[SUP] 1 [/SUP], Patricia de Gasperi[SUP] 1 [/SUP], Fernando P Hartwig[SUP] 1 [/SUP], Fernando C Barros[SUP] 1 [/SUP], Cesar G Victora[SUP] 1 [/SUP]



Affiliations

Abstract

Objectives. To evaluate the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) over 6 months in the Brazilian State of Rio Grande do Sul (population 11.3 million), based on 8 serological surveys. Methods. In each survey, 4151 participants in round 1 and 4460 participants in round 2 were randomly sampled from all state regions. We assessed presence of antibodies against SARS-CoV-2 using a validated lateral flow point-of-care test; we adjusted figures for the time-dependent decay of antibodies. Results. The SARS-CoV-2 antibody prevalence increased from 0.03% (95% confidence interval [CI] = 0.00%, 0.34%; 1 in every 3333 individuals) in mid-April to 1.89% (95% CI = 1.36%, 2.54%; 1 in every 53 individuals) in early September. Prevalence was similar across gender and skin color categories. Older adults were less likely to be infected than younger participants. The proportion of the population who reported leaving home daily increased from 21.4% (95% CI = 20.2%, 22.7%) to 33.2% (95% CI = 31.8%, 34.5%). Conclusions. SARS-CoV-2 infection increased slowly during the first 6 months in the state, differently from what was observed in other Brazilian regions. Future survey rounds will continue to document the spread of the pandemic. (Am J Public Health. Published online ahead of print June 29, 2021: e1-e9. https://doi.org/10.2105/AJPH.2021.306351).
 
Back
Top Bottom